Newsbytes

That’s very good. Kerry Foster, is there something you’d like to say in this context?

Kerry Foster: I see it as very much a win for Rob and a win for Orchard and all the employees and our customers and our prospects that will be joining us over the next few years.

Roche launches Navify cancer guidelines app

Roche has released the Navify Guidelines app as part of its Navify Decision Support portfolio.

The app embeds in Navify Tumor Board the latest National Comprehensive Cancer Network clinical practice guidelines in oncology covering the four most common cancers—breast, prostate, nonsmall cell lung, and colorectal.

When opening a patient case, the app identifies the appropriate guidelines based on the patient’s cancer type. Clinicians can then select the intended pathway, click through the digitized decision tree or flowchart, and personalize treatment steps. All Navify Tumor Board participants can access the app, and resulting treatment plans can be exported to be incorporated into a practice’s EMR system, sent to patients, and submitted to payers for reimbursement approval.

“The Navify Guidelines app provides clinicians with peace of mind that the latest clinical guidance has been considered in treatment decision-making and monitoring,” said Thomas Schinecker, CEO of Roche Diagnostics, in a press release. “The ability to facilitate and track guidelines adherence, personalization, and documentation supports evidence-based care for patients around the globe.”

Earlier this year, Roche released Navify Tumor Board 2.0, which integrates GE Healthcare’s medical image viewer, as part of a collaboration with GE Healthcare. In fall 2018, the company released the Navify Clinical Trial Match and Navify Publication Search clinical decision support apps to help oncology care teams find relevant clinical trials and literature, respectively.
Roche, 317-282-9415

Total Specific Solutions purchases Technidata

Netherlands-based Total Specific Solutions, a Constellation Software company and provider of information technology business solutions, has acquired the French laboratory software provider Technidata.

“Technidata’s entry into CSI group will allow it to benefit from the technological expertise of other subsidiaries of CSI group operating in the health care market,” according to a Technidata press release. “Technidata will also rely on the experience and strength of CSI to support its long-term investment programs.”

Technidata, which markets a variety of products in the United States, including the ^TDNexLabs lab information system and ^TDHarmony and ^TDBactiLink middleware, will operate as an independent business unit of Total Specific Solutions.
Technidata, 514-270-7777

Gestalt Diagnostics forms partnerships with Flagship Biosciences and MindPeak

Gestalt Diagnostics recently entered into strategic alliances with Flagship Biosciences and MindPeak for cancer pathology testing.

Gestalt and Flagship will collaborate on developing an integrated workflow that allows pathologists to access Flagship’s image-analysis services for digital images to support PD-L1 testing.

The companies are “engaging in a shared service to add Flagship’s computational services to Gestalt’s digital pathology solution, PathFlow,” according to a press release from Gestalt. PathFlow users will be able to request the PD-L1 image-analysis service through an interface.

“We are pleased to partner with Flagship Biosciences to integrate their machine learning/AI tools to provide cancer marker detection,” said Lisa Jean Clifford, Gestalt’s chief operating officer and chief strategy officer, in the release.

In a separate announcement, Gestalt and the German company MindPeak reported that they will work together to develop an integrated workflow for pathologists to instantaneously send regions of interest in breast cancer to MindPeak. MindPeak’s image-analysis services support the evaluation of estrogen receptor, progesterone receptor, and Ki-67 biomarkers for breast cancer diagnosis.

“By integrating with MindPeak, we are providing pathologists with the ability to select regions of interest on a digital image, automatically send that to MindPeak, and receive their annotated results back in real-time,” said Clifford, in the announcement.
Gestalt Diagnostics, 509-444-0630

Visiun enters group purchasing agreement

Visiun has been awarded a group purchasing agreement for its laboratory analytics system from the health care improvement company Premier.

The agreement allows Premier members to obtain special pricing for Visiun’s Performance Insight software, which provides business intelligence and analytics and is compatible with major laboratory information systems.

Premier offers its network of approximately 565,000 U.S. hospitals, health systems, and other providers group purchasing power; performance-improvement solutions; and consulting, advocacy, and other services.
Visiun, 877-226-6356

Dr. Aller teaches informatics in the Department of Pathology, University of Southern California, Los Angeles. He can be reached at raller@usc.edu. Hal Weiner is president of Weiner Consulting Services LLC, Eugene, Ore. He can be reached at hal@weinerconsulting.com.